Your browser doesn't support javascript.
loading
Invasive serogroup B meningococci in England following three years of 4CMenB vaccination - First real-world data.
Lucidarme, Jay; Bai, Xilian; Lekshmi, Aiswarya; Clark, Stephen A; Willerton, Laura; Ribeiro, Sonia; Campbell, Helen; Serino, Laura; De Paola, Rosita; Holland, Ann; Louth, Jennifer; Ramsay, Mary E; Ladhani, Shamez N; Borrow, Ray.
Affiliation
  • Lucidarme J; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom. Electronic address: jay.lucidarme@phe.gov.uk.
  • Bai X; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Lekshmi A; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Clark SA; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Willerton L; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Ribeiro S; Immunisation and Countermeasures Division, Public Health England, London, NW9 5EQ, United Kingdom.
  • Campbell H; Immunisation and Countermeasures Division, Public Health England, London, NW9 5EQ, United Kingdom.
  • Serino L; GlaxoSmithKline Vaccines, via Fiorentina 1, 53100, Siena, Italy.
  • De Paola R; GlaxoSmithKline Vaccines, via Fiorentina 1, 53100, Siena, Italy.
  • Holland A; Vaccine Evaluation Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Louth J; Vaccine Evaluation Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom.
  • Ramsay ME; Immunisation and Countermeasures Division, Public Health England, London, NW9 5EQ, United Kingdom.
  • Ladhani SN; Immunisation and Countermeasures Division, Public Health England, London, NW9 5EQ, United Kingdom; Paediatric Infectious Diseases Research Group, St. George's University of London, Cranmer Terrace, London SW17 0RE, United Kingdom.
  • Borrow R; Meningococcal Reference Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom; Vaccine Evaluation Unit, Public Health England, Floor 2 Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, M13 9WL, United Ki
J Infect ; 84(2): 136-144, 2022 02.
Article in En | MEDLINE | ID: mdl-34838814
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningococcal Infections Limits: Child, preschool / Humans / Infant Language: En Journal: J Infect Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningococcal Infections Limits: Child, preschool / Humans / Infant Language: En Journal: J Infect Year: 2022 Document type: Article